Before You Click On The "Read More" Link,
Please Only Do So If You Are Over 21 Years Old.
If You are Easily Upset, Triggered Or Offended, This Is Not The Place For You.
Please Leave Silently Into The Night......
Ninety miles from the South Eastern tip of the United States, Liberty has no stead. In order for Liberty to exist and thrive, Tyranny must be identified, recognized, confronted and extinguished.
British Plead with Biden to Extend Afghan Presence, Cannot Finish Evacuations Alone https://t.co/1eXpginNQJFrance and Germany have joined the UK in pressing Biden for more time to complete the evacuations from Afghanistan.
— Breitbart London (@BreitbartLondon) August 23, 2021
The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.The Pfizer vaccine—now called Comirnaty—is the first COVID-19 vaccine to receive FDA approval. Health officials are hoping the rushed authorization of the vaccine will encourage more unvaccinated people to get the jab.
To support the FDA’s approval decision today, the FDA reviewed updated data from the clinical trial which supported the EUA and included a longer duration of follow-up in a larger clinical trial population.There was no mention in the FDA’s statement of how many boosters might be required after the vaccine’s effectiveness wears off.
Specifically, in the FDA’s review for approval, the agency analyzed effectiveness data from approximately 20,000 vaccine and 20,000 placebo recipients ages 16 and older who did not have evidence of the COVID-19 virus infection within a week of receiving the second dose. The safety of Comirnaty was evaluated in approximately 22,000 people who received the vaccine and 22,000 people who received a placebo 16 years of age and older.